clinical 927 words KG: Lecanemab
Contents

Lecanemab CLARITY-AD Trial

No AI portrait yet

Knowledge Graph

Related Hypotheses (30)

Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.79
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.76
APOE Isoform Conversion Therapy
Score: 0.72
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.72
TREM2-Dependent Microglial Senescence Transition
Score: 0.95

Related Analyses (20)

Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
Epigenetic reprogramming in aging neurons
neurodegeneration · archived

Related Experiments (1)

Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40

See Also (15)

Dementia Australia
institution · KG edge: therapeutic_target
Amyloid-Related Imaging Abnormalities (ARIA)
entity · KG edge: implicated_in
Alzheimer Indonesia
institution · KG edge: treats
Aducanumab (Aduhelm)
therapeutic · KG edge: targets
APOE contributes to Alzheimer's disease by regulating b
hypothesis · KG edge: therapeutic_target

Knowledge Graph (12 edges)

Lecanemab treats Early-Stage Alzheimer's Disease
Lecanemab associated_with Amyloid-Beta Clearance
Lecanemab targets Brain Amyloid Pathology
Lecanemab causes Amyloid Related Imaging Abnormalities
Lecanemab causes Microhemorrhages
Anticoagulation interacts_with Lecanemab
Lecanemab causes Infusion Reactions
Lecanemab causes Macrohemorrhages
Lecanemab targets Amyloid-β
Lecanemab targets Amyloid Pathology

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)